Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
crispr
2
×
deals
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
startups
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
biogen
biotech
bluerock therapeutics
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
covid-19
david walt
deerfield management
detroit blog main
detroit top stories
diagnostics
durvalumab
editas medicine
europe blog main
europe top stories
fda
feng zhang
What
bio
2
×
medicines
2
×
years
acquisitions
announced
ceo
collabs
covid
create
crispr
daniel
deal
diagnostic
diseases
editing
fix
gene
gilead
gilead’s
heats
help
high
human
introduce
ipo
launches
month
o’day
plans
race
roundup
sciences
sherlock
stakes
technology
transformative
trials
underway
use
Language
unset
Current search:
crispr
×
bio
×
medicines
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
CRISPR Diagnostic Race Heats Up as Sherlock Bio Launches With $35M